Stephen Archer of Spring Partnerships looks back on months of M&A buzz in the pharma community, and examines whether the industry really stands to benefit from corporate buyouts.
The inspection confirmed the site to be compliant with the principles and guidelines of Good Manufacturing Practices (GMP) and no Form 483 observations were issued.
Testing testing: Diane Paskiet, director, scientific affairs, West Pharmaceutical Services explains how to understand risk from extractables and leachables (E&L) and the key quality considerations when designing E&L studies
It’s important to keep on top of the latest services, companies and individuals. EPM’s Chemical Reaction highlights a technology or business we think would be worth your while keeping in the mix . . .
The pharmaceutical manufacturers’ specialism in drug development, manufacturing and packaging services will complement PCI’s growth in clinical trial and commercial supply services in both North America and Europe.
Money matters: The most cost-effective way to produce pharmaceuticals is to develop an understanding of the critical phases involved, explains Mark Bosley, Purite.
